中文
EN
News Center
News Center
Innovation Drives Development, Focus Makes a "Little Giant": Viwit Recognized as a National Specialized, Refined, Distinctive, and Innovative "Little Giant" Enterprise in the Seventh Batch!
Author：
VIWIT
Release Time：
2026-01-29
On October 20, the Department of Industry and Information Technology of Shandong Province announced the public list of the seventh batch of national-level Specialized, Refined, Distinctive, and Innovative "Little Giant" enterprises for 2025. Viwit Pharmaceuticals Co., Ltd. has been successfully selected. This recognition marks authoritative national-level approval of Viwit's achievements in specialized, refined, distinctive, and innovative development, particularly highlighting its leading position in the domestic borane products sector.
National Specialized, Refined, Distinctive, and Innovative "Little Giant" enterprises represent the core force of high-quality small and medium-sized enterprises. They demonstrate professional technical advantages and sustained innovation capabilities within specific market segments, long-term focus on niche markets, outstanding innovation, leading market share, mastery of key core technologies, and remarkable quality and benefits. They serve as the "vanguard" in the development of the real economy.
As a leading enterprise in China's borane field, Viwit has been deeply rooted in this segment for nearly two decades. Building on its borane technology foundation, the company has expanded to cover innovative drugs, differentiated generic drugs, and active pharmaceutical ingredients (APIs), forming a complete pharmaceutical industry chain composed of four major business segments. This demonstrates the core competitiveness of its "specialized and refined" technological system.
Being honored as a national Specialized, Refined, Distinctive, and Innovative "Little Giant" enterprise is not only a commendation for Viwit's past achievements but also an impetus for its future development. Viwit will seize this opportunity to further deepen its innovation-driven strategy, increase R&D investment, accelerate the transformation of scientific and technological achievements, and commit to providing more high-quality and high-efficacy pharmaceutical products to the market. The company will contribute "Viwit's strength" to the development of the pharmaceutical and health industry in Shandong Province and across the nation.